Can a CSR be signed electronically?

Yes. Electronic signatures are valid under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws when intent, consent, attribution, and retention are met; check for any jurisdictional or trial-specific exceptions.

Do patient records in a CSR require HIPAA protections?

Yes. Any protected health information included in a CSR must be handled per HIPAA; when using third-party services, a Business Associate Agreement (BAA) may be required to protect PHI.

Which signers must sign the report?

Authorized study signatories typically include the principal investigator, medical writer or sponsor signatory, and a quality assurance approver; signatory authority should be defined in sponsor SOPs or delegation logs.

Is notarization required for CSRs?

Not generally. Clinical Study Reports do not usually require notarization, but specific institutional or sponsor policies may request witness or certification steps for legal certainty.

How long must a signed CSR be retained?

Retention depends on regulatory and sponsor rules; follow federal and HIPAA minimums (e.g., 3 years for many financial records, 6 years for HIPAA) and sponsor policies for longer retention.

What if signers are in different countries?

Cross-border signatures are generally allowed but must comply with ESIGN/UETA where U.S. law applies and consider local e-signature regulations abroad; verify export controls and data transfer rules when PHI is involved.

Electronic Signature
Templates
Miscellaneous
Clinical Study Report Template

Clinical Study Report Template

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

CLINICAL STUDY REPORT TEMPLATE AND AGREEMENT

This Clinical Study Report Template and Agreement (the Agreement) is made and entered into between:

Sponsor (Client) Name: Provider (Investigator or CRO) Name:

Whereas

WHEREAS, Sponsor (Client) Name: has commissioned Provider Name: to prepare a Clinical Study Report (CSR) in accordance with the study protocol and applicable regulations; and

WHEREAS, Provider represents that it has the personnel, facilities and expertise necessary to prepare, compile and deliver a complete, accurate and auditable CSR and associated appendices, tables and analyses; and

WHEREAS, the parties wish to set forth the scope, deliverables, payment terms and legal terms governing the preparation and delivery of the CSR.

Scope of Work

Provider shall prepare and deliver a Clinical Study Report for the study identified below. The CSR shall conform to applicable regulatory guidance and shall include all sections, analyses and appendices identified in this agreement.

Detailed Scope of Work (describe deliverables, format, and acceptance criteria):

Clinical Study Report — Key Identifiers

Study Title:

Protocol Number: Investigational Product:

Study Phase: Study Report Version:

Report Date:

Study Period: From to

Synopsis and Core Sections

Primary Objectives (brief): Secondary Objectives (brief): Study Design Summary: Subject Disposition: Efficacy Results (summary): Safety Results (summary): Statistical Methods and Analysis (describe primary analyses): Conclusions and Interpretation: Appendices and Supporting Documents (list):

Payment Terms

Total Fee (USD):

Payment Schedule (milestones and amounts):

Late Payment Fee (if payment not received within specified days):

Term and Termination

Agreement Effective Date: Term Expiration Date:

Either party may terminate for convenience upon days' prior written notice. Termination for cause may be effected immediately where the other party materially breaches and fails to cure within days following written notice.

Confidentiality

Each party acknowledges that in connection with performance of this Agreement it may receive Confidential Information of the other party. Confidential Information shall mean all non-public information disclosed in any form that is designated confidential or by its nature should reasonably be understood to be confidential.

Recipient shall: (a) use Confidential Information solely for performance under this Agreement; (b) protect the Confidential Information with at least the same degree of care it uses to protect its own confidential information but in no event less than reasonable care; and (c) not disclose Confidential Information to any third party except as expressly permitted herein. Exclusions: information that is independently developed, publicly known through no breach, rightfully received from a third party without restriction, or required to be disclosed by law.

Acknowledge Confidentiality Obligations: I agree to the confidentiality terms above.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of law principles.

Entire Agreement

This Agreement, including the Scope of Work and any attachments expressly incorporated herein, constitutes the entire understanding between the parties with respect to the subject matter and supersedes all prior and contemporaneous agreements, proposals and communications, whether written or oral. Any modification to this Agreement must be in writing and signed by authorized representatives of both parties.

Certifications and Author Responsibilities

The undersigned authors and signatories certify that the CSR will be prepared in accordance with the study protocol, the statistical analysis plan, and good clinical practice. All data presented will be true and accurate to the best of the preparers' knowledge, and any known limitations or deviations will be disclosed in the report.

Lead Author / Medical Writer Name: Lead Statistician Name: Additional Contributors (list names and roles):

Sponsor Representative Name:

By:

Date:

Provider Representative Name:

By:

Date:

What the Clinical Study Report Template Is

The Clinical Study Report Template is a standardized document framework used to record the design, conduct, results, and interpretation of a clinical trial. It consolidates trial metadata, methods, statistical analyses, safety findings, and regulatory conclusions in a consistent format suitable for sponsor review, institutional review boards, regulatory submissions, and archival. The template helps teams produce a complete, auditable narrative that maps raw data to conclusions and supports regulatory decisions, publication, and long-term recordkeeping across stakeholders in the study lifecycle.

Why a Standardized Clinical Study Report Template Matters

A template reduces omissions, enforces consistent sections for methods and results, and supports regulatory expectations for traceability and reproducibility.

Who Prepares and Reviews Clinical Study Reports

Multiple stakeholders sign off on sections; distribution usually follows a formal approval and submission plan tailored to the trial and jurisdiction.

Study Sponsor teams and clinical operations: draft, approve, and submit CSR content for regulatory review and internal governance.
CRO clinical teams and biostatisticians: compile methods, datasets, and analysis summaries to populate CSR sections.
Regulatory affairs, medical writers, and IRB/IEC reviewers: review for completeness, regulatory compliance, and ethics oversight.

Step-by-Step: Completing the Clinical Study Report Template

Follow a consistent sequence to gather source materials, draft sections, verify analyses, and obtain approvals for a complete CSR.

01

Gather documents: Collect protocol, SAP, CRFs, safety narratives, and dataset definitions.
02

Draft sections: Populate background, methods, results, and discussion using source-validation notes.
03

Verify analyses: Confirm tables and figures against statistical outputs and the SAP.
04

Approve and sign: Route for signatures in role order, then archive the signed CSR.

Core Sections Every Professional Clinical Study Report Should Include

A complete CSR groups technical, analytical, and administrative information so reviewers can follow study rationale, execution, and conclusions.

Title Page

Study title, protocol number, sponsor, investigational product, and effective date. Serves as the primary identifier for regulatory filing and indexing.

Synopsis

Condensed overview of objectives, design, population, key efficacy and safety results, and conclusions to guide reviewers who need a quick assessment.

Methods

Detailed description of trial design, inclusion/exclusion criteria, randomization, blinding, interventions, and statistical analysis plan to ensure reproducibility.

Results

Participant disposition, baseline characteristics, efficacy analyses, safety summaries, and adverse event listings with tables and figures linked to datasets.

Discussion

Interpretation of findings, limitations, clinical relevance, and comparison with prior evidence to support regulatory and clinical conclusions.

Appendices

CRF pages, dataset listings, SAP, investigator brochures, and audit trail extracts that substantiate main-text claims and permit secondary review.

Required Identifiers and Security Metadata

Study ID: Sponsor protocol number

Version Control: Document version ID

Access Controls: Role-based permissions

Audit Trail: Timestamps and user actions

Data Masking: Redaction of PHI when required

Retention Tag: Record lifecycle label

Where to File, Send, and Submit a Completed CSR

Submission routes depend on study type, sponsor procedures, and regulatory requirements; planning distribution avoids delays and re-requests.

Sponsor Archive: Upload final signed CSR to sponsor document management systems for long-term retention.
Regulatory Submission: Transmit required sections to regulatory authorities per jurisdictional e-submission guidance.
Institutional Records: Provide investigators and IRB/IEC with certified copies for local files.
ClinicalTrials.gov: Post summary results when applicable, following registry submission rules.

How to Configure an Online Completion Workflow

Set up automated routing and role-based signing to enforce sequence, authenticate signers, and capture audit trails.

Field	Configuration
Signer Roles	Define order and permissions for each approver
Authentication Level	Specify email, SMS, or stronger methods
Conditional Fields	Show fields only when relevant inputs are present
Retention Settings	Apply archival and access policies

Digital Signing and eSubmission Considerations

Ensure the platform can export signed documents with embedded audit logs and retain copies consistent with applicable recordkeeping rules.

File Formats: PDF/A and DOCX supported
Authentication: Email, SMS, or advanced MFA
Integrations: Connectors for EDC and DMS

Typical Timelines and Deadlines for Clinical Study Report Delivery

Timelines vary by sponsor and regulatory authority; build deadlines into the study closeout plan and allocate time for review, revisions, and approvals.

Final CSR Preparation:

Typically begins after database lock; schedule 4–12 weeks depending on complexity

Internal Review:

Allow 2–4 weeks for cross-functional review cycles

Regulatory Submission:

Follow agency-specific submission windows or sponsor commitments

Public Registry Posting:

Comply with ClinicalTrials.gov or registry deadlines when applicable

Archival:

Store signed CSR immediately after final approval

Key Milestones from Database Lock to Archival

A clear milestone sequence reduces bottlenecks and clarifies who is responsible at each stage.

01

Database Lock

Finalize dataset and freeze source for analysis

02

Statistical Analysis

Complete pre-specified and sensitivity analyses

03

Drafting and Review

Prepare CSR draft and execute multidisciplinary review

04

Signing and Archival

Obtain signatures, export signed CSR, and archive per retention policy

Best Practices to Improve Accuracy and Efficiency

Adopt consistent habits that reduce rework, speed approvals, and strengthen auditability of CSR content.

Use a controlled template

Maintain a single master template with version control to avoid conflicting section structures and to ensure consistent indexing when assembling appendices and tables.

Link evidence to text

Annotate key results with dataset identifiers and analysis program references so reviewers can trace summaries back to source outputs and reproduce findings if required.

Enforce signatory roles

Define and document who may sign each CSR section, require role-based authentication, and log approvals to meet regulatory expectations for accountability.

Plan retention early

Apply retention labels based on record type and legal requirements to ensure documents are preserved for the required statutory periods and are discoverable if inspected.

Common Mistakes to Avoid When Preparing a CSR

Inconsistent identifiers across datasets and text that prevent matching tables to source outputs and trigger regulatory questions.
Incomplete safety narratives or missing investigator information that lead to requests for clarifying data and delay submission.
Failure to capture or export an audit trail for edits and approvals, reducing trust in the document's integrity.
Incorrect or missing effective dates and version numbers that create ambiguity about which report is final.

Penalties and Risks of Incomplete or Incorrect CSRs

Regulatory Delay: Submission holds

Query Requests: Extended review cycles

Reputational Risk: Sponsor credibility loss

Data Integrity Issues: Potential findings on inspection

Legal Exposure: Contractual breach claims

Patient Safety Risk: Delayed safety signals

eSignature Vendor Pricing and Feature Comparison

Compare core pricing and compliance features for e-signature vendors when selecting a platform for Clinical Study Report signing and archival.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes (bulk on Premium)	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

FAQs: Common Questions About Using a Clinical Study Report Template

Answers to frequent practical and compliance questions when preparing, signing, and archiving a CSR using electronic workflows.

Need help? Contact support

Can a CSR be signed electronically?
Yes. Electronic signatures are valid under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA laws when intent, consent, attribution, and retention are met; check for any jurisdictional or trial-specific exceptions.
Do patient records in a CSR require HIPAA protections?
Yes. Any protected health information included in a CSR must be handled per HIPAA; when using third-party services, a Business Associate Agreement (BAA) may be required to protect PHI.
Which signers must sign the report?
Authorized study signatories typically include the principal investigator, medical writer or sponsor signatory, and a quality assurance approver; signatory authority should be defined in sponsor SOPs or delegation logs.
Is notarization required for CSRs?
Not generally. Clinical Study Reports do not usually require notarization, but specific institutional or sponsor policies may request witness or certification steps for legal certainty.
How long must a signed CSR be retained?
Retention depends on regulatory and sponsor rules; follow federal and HIPAA minimums (e.g., 3 years for many financial records, 6 years for HIPAA) and sponsor policies for longer retention.
What if signers are in different countries?
Cross-border signatures are generally allowed but must comply with ESIGN/UETA where U.S. law applies and consider local e-signature regulations abroad; verify export controls and data transfer rules when PHI is involved.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now